Abstract:Objective: Changes in gut microbiota have been linked to systemic lupus erythematosus (SLE), but knowledge is limited. Our study aimed to provide an in-depth understanding of the contribution of gut microbiota to the immunopathogenesis of SLE. Methods: Fecal metagenomes from 117 patients with untreated SLE and 52 SLE patients posttreatment were aligned with 115 matched healthy controls and analyzed by whole-genome profiling. For comparison, we assessed the fecal metagenome of MRL/lpr mice. The oral microbiota origin of the gut species that existed in SLE patients was documented by single-nucleotide polymorphism-based strain-level analyses. Functional validation assays were performed to demonstrate the molecular mimicry of newly found microbial peptides. Results: Gut microbiota from individuals with SLE displayed significant differences in microbial composition and function compared to healthy controls. Certain species, including the Clostridium species ATCC BAA-442 as well as Atopobium rimae, Shuttleworthia satelles, Actinomyces massiliensis, Bacteroides fragilis, and Clostridium leptum, were enriched in SLE gut microbiota and reduced after treatment. Enhanced lipopolysaccharide biosynthesis aligned with reduced branched chain amino acid biosynthesis was observed in the gut of SLE patients. The findings in mice were consistent with our findings in human subjects. Interestingly, some species with an oral microbiota origin were enriched in the gut of SLE patients. Functional validation assays demonstrated the proinflammatory capacities of some microbial peptides derived from SLE-enriched species. Conclusion: This study provides detailed information on the microbiota of untreated patients with SLE, including their functional signatures, similarities with murine counterparts, oral origin, and the definition of autoantigen-mimicking peptides. Our data demonstrate that microbiome-altering approaches may offer valuable adjuvant therapies in SLE.

Gut pathobiont translocation induces lymphocyte migration to internal organs in autoimmunity

Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus

A dynamic atlas of immunocyte migration from the gut

Gut Microbiota in Systemic Lupus Erythematosus: A Fuse and a Solution

Gut epithelial barrier dysfunction in lupus triggers a differential humoral response against gut commensals

Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut

Regulation of Autoimmunity by the Microbiome

Gut Microbiota Translocation Promotes Autoimmune Cholangitis

Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation

Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity

Sex-dependent Lupus Blautia (Ruminococcus) gnavus strain induction of zonulin-mediated intestinal permeability and autoimmunity

The systemic anti-microbiota IgG repertoire can identify gut bacteria that translocate across gut barrier surfaces

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus

Contribution of gut-derived T cells to extraintestinal autoimmune diseases

Lymph node sharing between pancreas, gut, and liver leads to immune crosstalk and regulation of pancreatic autoimmunity

Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site

Gut microbiota regulate migration of lymphocytes from gut to lung

Synergy between intraepithelial lymphocytes and lamina propria T cells drives intestinal inflammation during infection

Gut microbiota in systemic lupus erythematosus pathogenesis: an in-depth view of mechanisms inside

Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer's Patch T Follicular Helper Cells